Apoptosis Technology, Inc.
Records under this name other than patents Apoptosis Technology, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Apoptosis Technology, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,605,426 | Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products Lapsed on the fee record Ended Aug 12, 2015 · From the USPTO record | Lapsed on the fee record | Ended Aug 12, 2015 | From the USPTO record |
| US 6,586,204 | Apoptosis gene EI24, compositions, and methods of use Lapsed on the fee record Ended Jul 1, 2015 · From the USPTO record | Lapsed on the fee record | Ended Jul 1, 2015 | From the USPTO record |
| US 7,193,044 | Compounds and methods for regulating apoptosis, and methods of making and screening for compounds that regulate apoptosis Lapsed on the fee record Ended Mar 20, 2015 · From the USPTO record | Lapsed on the fee record | Ended Mar 20, 2015 | From the USPTO record |
| US 7,097,982 | Peptides and compositions which modulate apoptosis Lapsed on the fee record Ended Aug 29, 2014 · From the USPTO record | Lapsed on the fee record | Ended Aug 29, 2014 | From the USPTO record |
| US 6,902,885 | Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products Lapsed on the fee record Ended Jun 7, 2013 · From the USPTO record | Lapsed on the fee record | Ended Jun 7, 2013 | From the USPTO record |
| US 6,221,615 | Peptides and compositions which modulate apoptosis Lapsed on the fee record Ended Apr 24, 2013 · From the USPTO record | Lapsed on the fee record | Ended Apr 24, 2013 | From the USPTO record |
| US 6,218,511 | Anti-apoptotic genes of human cytomegalovirus (HCMV) and their use Lapsed on the fee record Ended Apr 17, 2013 · From the USPTO record | Lapsed on the fee record | Ended Apr 17, 2013 | From the USPTO record |
| US 7,449,450 | Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products Formerly held Lapsed on the fee record Ended Nov 11, 2012 · From the USPTO record | Lapsed on the fee record | Ended Nov 11, 2012 | From the USPTO record |
| US 7,358,088 | Peptides and compositions which modulate apoptosis Formerly held Lapsed on the fee record Ended Apr 15, 2012 · From the USPTO record | Lapsed on the fee record | Ended Apr 15, 2012 | From the USPTO record |
| US 6,596,473 | Active survival domains of IGF-IR and methods of use Lapsed on the fee record Ended Jul 22, 2007 · From the USPTO record | Lapsed on the fee record | Ended Jul 22, 2007 | From the USPTO record |